Urology
Volume 64, Issue 5 , Pages 959-965 , November 2004

Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: The Flint Men’s Health Study

  • Aruna V. Sarma

      Affiliations

    • Department of Urology, University of Michigan Health System, Ann Arbor, Michigan, USA
    • Department of Epidemiology, University of Michigan Health System, Ann Arbor, Michigan, USA
    • Corresponding Author InformationReprint requests: Aruna V. Sarma, M.D., Department of Urology, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0759
    • A. V. Sarma owns stock in GlaxoSmithKline and J. Logie and P. Dolin are employees of GlaxoSmithKline.
    • ,
  • Julie C. McLaughlin

      Affiliations

    • Department of Urology, University of Michigan Health System, Ann Arbor, Michigan, USA
    • ,
  • Steven J. Jacobsen

      Affiliations

    • Department of Clinical Epidemiology, Mayo Clinic, Rochester, Minnesota, USA
    • ,
  • John Logie

      Affiliations

    • Department of Worldwide Epidemiology, GlaxoSmithKline Research and Development, Greenford, United Kingdom
    • ,
  • Paul Dolin

      Affiliations

    • Department of Worldwide Epidemiology, GlaxoSmithKline Research and Development, Greenford, United Kingdom
    • ,
  • Rodney L. Dunn

      Affiliations

    • Department of Urology, University of Michigan Health System, Ann Arbor, Michigan, USA
    • ,
  • Kathleen A. Cooney

      Affiliations

    • Department of Urology, University of Michigan Health System, Ann Arbor, Michigan, USA
    • Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA
    • ,
  • James E. Montie

      Affiliations

    • Department of Urology, University of Michigan Health System, Ann Arbor, Michigan, USA
    • ,
  • David Schottenfeld

      Affiliations

    • Department of Epidemiology, University of Michigan Health System, Ann Arbor, Michigan, USA
    • Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA
    • ,
  • John T. Wei

      Affiliations

    • Department of Urology, University of Michigan Health System, Ann Arbor, Michigan, USA

Received 11 December 2003 ,Accepted 17 June 2004.

References 

  1. Berry SJ , Coffey DS , Walsh PC , et al.   The development of human benign prostatic hyperplasia with age . J Urol . 1984;132:474–479
  2. Jacobsen SJ , Girman CJ , Lieber MM . Natural history of benign prostatic hyperplasia . Urology . 2001;58(6 suppl 1):5–16
  3. Girman CJ , Jacobsen SJ , Tsukamoto T , et al.   Health-related quality of life associated with lower urinary tract symptoms in four countries . Urology . 1998;51:428–436
  4. Roberts RO , Rhodes T , Panser LA , et al.   Natural history of prostatism (worry and embarrassment from urinary symptoms and health care-seeking behavior) . Urology . 1994;43:621–628
  5. Roberts RO , Jacobsen SJ , Rhodes T , et al.   Natural history of prostatism (impaired health states in men with lower urinary tract symptoms) . J Urol . 1997;157:1711–1717
  6. Trueman P , Hood SC , Nayak US , et al.   Prevalence of lower urinary tract symptoms and self-reported diagnosed “benign prostatic hyperplasia,” and their effect on quality of life in a community-based survey of men in the UK . BJU Int . 1999;83:410–415
  7. Jacobsen SJ , Girman CJ , Guess HA , et al.   Natural history of prostatism (longitudinal changes in voiding symptoms in community dwelling men) . J Urol . 1996;155:595–600
  8. Sarma AV , Wei JT , Jacobson DJ , et al.   Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men (the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men’s Health Study) . Urology . 2003;61:1086–1091
  9. Cooney KA , Strawderman MS , Wojno KJ , et al.   Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men . Urology . 2001;57:91–96
  10. Sarma AV , Jaffe CA , Schottenfeld D , et al.   Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index (clinical correlates of prostate volume among black men) . Urology . 2002;59:362–367
  11. Barry MJ , Fowler FJ , O’Leary MP , et al.  Measurement Committee of the American Urological Association   Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes . J Urol . 1992;148:1558–1563
  12. Barry MJ , Fowler FJ , O’Leary MP , et al.  Measurement Committee of the American Urological Association   The American Urological Association symptom index for benign prostatic hyperplasia . J Urol . 1992;148:1549–1557
  13. Barry MJ , O’Leary MP . Advances in benign prostatic hyperplasia (the developmental and clinical utility of symptom scores) . Urol Clin North Am . 1995;22:299–307
  14. Corica FA , Jacobsen SJ , King BF , et al.   Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men . J Urol . 1999;161:831–834
  15. Guess HA , Chute CG , Garraway WM , et al.   Similar levels of urological symptoms have similar impact on Scottish and American men—although Scots report less symptoms . J Urol . 1993;150(5 Pt 2):1701–1705
  16. Kaplan SA , Olsson CA , Te AE . The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms (at 2 years of followup, does it work?) . J Urol . 1996;155:1971–1974
  17. Wei JT , Schottenfeld D , Cooper K , et al.   The natural history of lower urinary tract symptoms in black American men (relationships with aging, prostate size, flow rate and bothersomeness) . J Urol . 2001;165:1521–1525
  18. Girman CJ , Epstein RS , Jacobsen SJ , et al.   Natural history of prostatism (impact of urinary symptoms on quality of life in 2115 randomly selected community men) . Urology . 1994;44:825–831
  19. Masumori N , Tsukamoto T , Kumamoto Y , et al.   Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men (results of community based studies in 2 countries) . J Urol . 1996;155:1324–1327
  20. Tan HY , Choo WC , Archibald C , et al.   A community based study of prostatic symptoms in Singapore . J Urol . 1997;157:890–893
  21. Tsukamoto T , Kumamoto Y , Masumori N , et al.   Prevalence of prostatism in Japanese men in a community-based study with comparison to a similar American study . J Urol . 1995;154(2 Pt 1):391–395
  22. Lee AJ , Garraway WM , Simpson RJ , et al.   The natural history of untreated lower urinary tract symptoms in middle-aged and elderly men over a period of five years . Eur Urol . 1998;34:325–332
  23. Barry MJ , Fowler FJ , Bin L , et al.   The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists . J Urol . 1997;157:10–14
  24. Flanigan RC , Reda DJ , Wasson JH , et al.   5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia (a Department of Veterans Affairs cooperative study) . J Urol . 1998;160:12–16
  25. Lee AJ , Russell EB , Garraway WM , et al.   Three-year follow-up of a community-based cohort of men with untreated benign prostatic hyperplasia . Eur Urol . 1996;30:11–17
  26. Meigs JB , Barry MJ , Giovannucci E , et al.   Incidence rates and risk factors for acute urinary retention (the Health Professionals Followup study) . J Urol . 1999;162:376–382
  27. Wasson JH , Reda DJ , Bruskewitz RC , et al.  Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate   A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia . N Engl J Med . 1995;332:75–79
  28. Heeringa SG , Alcser KH , Doerr K , et al.   Potential selection bias in a community-based study of PSA levels in African-American men . J Clin Epidemiol . 2001;54:142–148

 This study was supported by U.S. Public Health Service grants P50CA69568 (National Cancer Institute) and T32DK07758 (National Institute of Diabetes and Digestive and Kidney Diseases) and GlaxoSmithKline Pharmaceuticals.

PII: S0090-4295(04)00805-2

doi: 10.1016/j.urology.2004.06.043

Urology
Volume 64, Issue 5 , Pages 959-965 , November 2004

Article Tools

* Image Usage & Resolution